University of Massachusetts

Recent Events

News & Analysis

biotechnology and university of massachusetts - All News and Analysis

• CytRx Announces RNAi Delivery Nanoparticle Technology Exclusively Licensed to Subsidiary, RXi Pharmaceuticals, Described in Peer-Reviewed Journal

  - 2007-04-23

  LOS ANGELES -- CytRx Corporation (NASDAQ:CYTR) today announced that the RNA interference RNAi delivery technology exclusively licensed to its majority-owned subsidiary, RXi Pharmaceuticals Corporation RXi, has been published in the April 2007 issue of peer-reviewed scientific journal ACS Chemical Biology. The technology was developed by RXi Co-founder, Scientific Advisory Board...

  Tags: Biotechnology, Company, Government, RNA, University of Massachusetts

• CytRx Corp. Added to Bellwether Watch List.

  - 2007-01-16

  M2 PRESSWIRE-16 January 2007-Biotech News: CytRx Corp. Added to Bellwether Watch ListC1994-2007 M2 COMMUNICATIONS LTD RDATE:16012007 The only vowel CytRx needs is the A in RNA. CytRx has partnered with the medical school of the University of Massachusetts to develop treatments...

  Tags: Biotechnology, CytRx Corp., gene, RNA, University of Massachusetts

• Nobel knockout.

  - 2006-10-10

  Oct 10, 2006 (New Scientist - ABIX via COMTEX) -- US researchers have been awarded a Nobel prize for medicine for their work with genes. Andrew Fire, of Stanford University, and Craig Mello, of the University of Massachusetts, discovered how to "silence" genes with ribonucleic acid...

  Tags: Biotechnology, gene, RNA, Stanford University, University of Massachusetts

• US scientist Craig Mello, Nobel Medicine Prize co-laureate

  - 2006-10-02

  STOCKHOLM AFP — Craig Mello, who has won the Nobel Medicine Prize with Andrew Fire for their discovery on how to silence malfunctioning genes, is a 45-year-old US researcher whose passion for science was born digging for dinosaur bones with his father. Born on October 19, 1960, Mello is currently...

  Tags: Agence France-Presse, Biotechnology, SECURITY, University of Massachusetts

• CytoDyn Acquires Advanced Influenza Technologies, Inc. from UTEK Corporation; Acquisition Includes License to DNA-Based Influenza Vaccine

  - 2006-07-21

  SANTA FE, N.M. & TAMPA, Fla. -- CytoDyn, Inc. (OTCBB:CYDY), a development stage biotechnology company, and UTEK Corporation (AMEX:UTK) (LSE-AIM:UTK), a specialty finance company focused on technology transfer, announced today that CytoDyn has acquired Advanced Influenza Technologies, Inc. AIT, a wholly owned subsidiary of UTEK, in a stock transaction. AIT...

  Tags: acquisition, Biotechnology, DNA, HEALTHCARE, technology, University of Massachusetts, vaccine

• University of Massachusetts Amherst and Adventus Americas, Inc. Recognize Future Environmental Science Leaders; Remediation Biotechnology Firm Announces Winners of Its Annual Student Award Program

  - 2005-10-28

  AMHERST, Mass. -- Adventus Americas, Inc., an international remediation biotechnology firm, joined the University of Massachusetts Amherst to recognize talented, emerging environmental scientists during the 21st Annual International Conference on Soils, Sediments and Water held here recently.

  Tags: biotechnology, University of Massachusetts

• BIOTECHNOLOGY: Microbes Behave as Electrical Nanowires.(microbial nanowires)(Geobacter)

  - 2005-07-01

  Researchers at the University of Massachusetts Amherst have discovered a tiny biological structure that is highly electrically conductive. This breakthrough helps describe how microorganisms can clean up groundwater and produce electricity from renewable resources. It may also have important applications in electronic devices and environmental...

  Tags: biotechnology, cell, electron, oxygen, University of Massachusetts

• Sirna Therapeutics licenses seminal RNA interference technology.(to the University of Massachusetts Medical School)

  - 2003-09-01

  Sirna Therapeutics, Inc. (Boulder, CO) has entered into a worldwide license agreement with the University of Massachusetts Medical School (Worcester, MA) for its undivided interest in the seminal intellectual property on RNA interference RNAi technology covering short interfering RNA siRNA. This license significantly strengthens Sirna's...

  Tags: Biotechnology, RNA, University of Massachusetts

• Marine Resources Center programs.

  - 2003-08-01

  The Marine Resources Center MRC is a national center for the development and use of aquatic organisms in basic biological research, biomedical research, aquaculture, and fisheries science. The research programs focus on biological processes integrated at the level of the whole organism. ...

  Tags: Biotechnology, Boston University, G., HEALTHCARE, M., PRODUCTIVITY, scientist, University of Massachusetts

• Antisense chemistry interference involves Hybridon.

  - 2002-10-01

  Hybridon, Inc. (Cambridge, MA) announced that the United States Patent and Trademark Office has declared an interference between United States Patent Application 08/346,270 assigned to the University of Massachusetts (Amherst, MA) and three patents issued to the National Institutes of Health. The patent ...

  Tags: Biotechnology, DNA, patent, PTO, University of Massachusetts